UCB Pharma
345
8
11
286
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
10.1%
35 terminated/withdrawn out of 345 trials
89.1%
+2.6% vs industry average
50%
171 trials in Phase 3/4
48%
138 of 286 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (345)
Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
Role: collaborator
EEG Dynamics in Lennox-Gastaut Syndrome Patients Undergoing Fenfluramine Treatment
Role: collaborator
Bimekizumab in Plaque Psoriasis
Role: collaborator
Zilucoplan for Severe gMG Exacerbations
Role: collaborator
Detecting Fatigue From Voice in Generalised Myasthenia Gravis
Role: collaborator
Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care
Role: collaborator
Clinical Utility of Reduced EEG Home Monitoring in Fenfluramine Titration for Dravet and LGS
Role: collaborator
Brigham and Women's Rheumatoid Arthritis Sequential Study
Role: collaborator
Doxecitin and Doxribthymine in Adult Subjects With Thymidine Kinase 2 (TK2) Deficiency
Role: collaborator
Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment
Role: collaborator
The Personalized Parkinson Project De Novo Cohort
Role: collaborator
Personalized Parkinson Project PSP Cohort
Role: collaborator
Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
Role: collaborator
OTIS Cimzia Pregnancy Registry
Role: collaborator
PsoBest - The German Psoriasis Registry
Role: collaborator
Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age
Role: collaborator
To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate
Role: lead
Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
Role: lead
IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
Role: collaborator
An Investigation of Levetiracetam in Alzheimer's Disease
Role: collaborator